Dietary Flavonoid Hyperoside Induces Apoptosis of Activated Human LX-2 Hepatic Stellate Cell by Suppressing Canonical NF- B Signaling

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Wang, Liwen ^a,b   Yue, Zhiwei ^c   Guo, Mengzheng ^b   Fang, Lianying ^b   Bai, Liang ^a   Li, Xinyu ^a   Tao, Yongqing ^a   Wang, Suying ^a   Liu, Qiang ^b   Zhi, Dexian ^a   Zhao, Hui ^a  

^a TIANJIN UNIVERSITY OF COMMERCE   (China)

^b INSTITUTE OF RADIATION MEDICINE   (China)

^c NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

A20 PROTEIN; ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; C IAP1 PROTEIN; COLLAGEN TYPE 1; FAS ANTIGEN; FAS LIGAND; HLA DR4 ANTIGEN; HYPERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN BCL X; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; RIP1 PROTEIN; UNCLASSIFIED DRUG; FLAVONOID; QUERCETIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIVER FIBROSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; UPREGULATION; ANALOGS AND DERIVATIVES; CELL LINE; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; GENETIC DISORDER; HEPATIC STELLATE CELL; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

APOPTOSIS; CELL LINE; DIETARY SUPPLEMENTS; FLAVONOIDS; GENETIC DISEASES, INBORN; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; NF-KAPPA B; QUERCETIN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84971441785     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/1068528     Document Type: Article

References (47)

1. P. Angulo, D. E. Kleiner, S. Dam-Larsen et al., "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease, " Gastroenterology, vol. 149, no. 2, pp. 389. e10-397. e10, 2015.
2. V. Hernandez-Gea and S. L. Friedman, "Pathogenesis of liver fibrosis, " Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 425-456, 2011.
3. D. Schuppan andN. H. Afdhal, "Liver cirrhosis, "TheLancet, vol. 371, no. 9615, pp. 838-851, 2008.
4. H. B. El-Serag and K. L. Rudolph, "Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, " Gastroenterology, vol. 132, no. 7, pp. 2557-2576, 2007.
5. R. I. A. Rippe and D. A. A. Brenner, "Fromquiescence to activation: gene regulation in hepatic stellate cells, " Gastroenterology, vol. 127, no. 4, pp. 1260-1262, 2004.
6. A. Anan, E. S. Baskin-Bey, S. F. Bronk, N. W. Werneburg, V. H. Shah, and G. J. Gores, "Proteasome inhibition induces hepatic stellate cell apoptosis, " Hepatology, vol. 43, no. 2, pp. 335-344, 2006.
7. M. C. Wright, R. Issa, D. E. Smart et al., "Gliotoxinstimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats, " Gastroenterology, vol. 121, no. 3, pp. 685-698, 2001.
8. E. Crosas-Molist, E. Bertran, and I. Fabregat, "Cross-talk between TGF-and NADPH oxidases during liver fibrosis and hepatocarcinogenesis, " Current Pharmaceutical Design, vol. 21, no. 41, pp. 5964-5976, 2015.
9. T. D. Gilmore, "Introduction to NF-B: players, pathways, perspectives, " Oncogene, vol. 25, no. 51, pp. 6680-6684, 2006.
10. T. Luedde and R. F. Schwabe, "NF-B in the liver-linking injury, fibrosis and hepatocellular carcinoma, " Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 2, pp. 108-118, 2011.
11. F. Oakley, M. Meso, J. P. Iredale et al., "Inhibition of inhibitor of b kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis, " Gastroenterology, vol. 128, no. 1, pp. 108-120, 2005.
12. A. M. Elsharkawy, F. Oakley, and D. A. Mann, "The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis, " Apoptosis, vol. 10, no. 5, pp. 927-939, 2005.
13. D. F. Romagnolo and O. I. Selmin, "Flavonoids and cancer prevention: a review of the evidence, " Journal of Nutrition in Gerontology and Geriatrics, vol. 31, no. 3, pp. 206-238, 2012.
14. D. Sampietro, E. Quiroga, M. Sgariglia, J. Soberón, and M. A. Vattuone, "A thermostable-galactosidase from Lenzites elegans (Spreng. ) ex Pat. MB445947: purification and properties, " Antonie van Leeuwenhoek, vol. 102, no. 2, pp. 257-267, 2012.
15. S. Trumbeckaite, J. Bernatoniene, D. Majiene, V. JaKstas, A. Savickas, and A. Toleikis, "The effect of flavonoids on rat heart mitochondrial function, " Biomedicine and Pharmacotherapy, vol. 60, no. 5, pp. 245-248, 2006.
16. W. Zhou, J. Oh, W. Li, D. W. Kim, S. H. Lee, and M. K. Na, "Phytochemical studies of Korean endangered plants: a new flavone from Rhododendron brachycarpum G. Don, " Bulletin of the Korean Chemical Society, vol. 34, no. 8, pp. 2535-2538, 2013.
17. S.-K. Ku, S. Kwak, O.-J. Kwon, and J.-S. Bae, "Hyperoside inhibits high-glucose-induced vascular inflammation in vitro and in vivo, " Inflammation, vol. 37, no. 5, pp. 1389-1400, 2014.
18. L.-L. Wu, X.-B. Yang, Z.-M. Huang, H.-Z. Liu, and G.-X. Wu, "In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik, " Acta Pharmacologica Sinica, vol. 28, no. 3, pp. 404-409, 2007.
19. L. Xu, A. Y. Hui, E. Albanis et al., "Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis, " Gut, vol. 54, no. 1, pp. 142-151, 2005.
20. D. Diaz, A. Prieto, E. Reyes, H. Barcenilla, J. Monserrat, and M. Alvarez-Mon, "Flow cytometry enumeration of apoptotic cancer cells by apoptotic rate, " Methods in Molecular Biology, vol. 1219, pp. 11-20, 2015.
21. C. Zhu, Z. Lei, and Y. Luo, "Studies on antioxidative activities of methanol extract from Murraya paniculata, " Food Science and Human Wellness, vol. 4, no. 3, pp. 108-114, 2015.
22. S. De Minicis and D. A. Brenner, "NOX in liver fibrosis, " Archives of Biochemistry and Biophysics, vol. 462, no. 2, pp. 266-272, 2007.
23. Y.-H. Paik, K. Iwaisako, E. Seki et al., "Thenicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice, " Hepatology, vol. 53, no. 5, pp. 1730-1741, 2011.
24. J. Kucharczak, M. J. Simmons, Y. Fan, and C. Gélinas, "To be, or not to be: NF-B is the answer-role of Rel/NF-B in the regulation of apoptosis, " Oncogene, vol. 22, no. 56, pp. 8961-8982, 2003.
25. S. K. Radhakrishnan and S. Kamalakaran, "Pro-apoptotic role of NF-B: implications for cancer therapy, " Biochimica et Biophysica Acta-Reviews on Cancer, vol. 1766, no. 1, pp. 53-62, 2006.
26. P. MadanKumar, P. NaveenKumar, S. Manikandan, H. Devaraj, and S. NiranjaliDevaraj, "Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/-catenin signaling, " Toxicology and Applied Pharmacology, vol. 277, no. 2, pp. 210-220, 2014.
27. S. M. Elshazly and A. A. A. Mahmoud, "Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats, " Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 387, no. 6, pp. 559-567, 2014.
28. S. Clichici, D. Olteanu, A.-L. Nagy, A. Oros, A. Filip, and P. A. Mircea, "Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl4-treated rats, " Journal of Medicinal Food, vol. 18, no. 3, pp. 290-298, 2015.
29. S.-K. Ku, T. H. Kim, S. Lee, S. M. Kim, and J.-S. Bae, "Antithrombotic and profibrinolytic activities of isorhamnetin-3-O-galactoside and hyperoside, " Food and Chemical Toxicology, vol. 53, pp. 197-204, 2013.
30. Z.-L. Li, J. Hu, Y.-L. Li et al., "The effect of hyperoside on the functional recovery of the ischemic/reperfused isolated rat heart: potential involvement of the extracellular signalregulated kinase 1/2 signaling pathway, " Free Radical Biology and Medicine, vol. 57, pp. 132-140, 2013.
31. S. Lee, H. J. Sang, S. L. Yeon et al., "Antiinflammatory activity of hyperin from Acanthopanax chiisanensis roots, " Archives of Pharmacal Research, vol. 27, no. 6, pp. 628-632, 2004.
32. J.-H. Choi, D.-W. Kim, N. Yun et al., "Protective effects of hyperoside against carbon tetrachloride-induced liver damage in mice, " Journal of Natural Products, vol. 74, no. 5, pp. 1055-1060, 2011.
33. V. Sivaramakrishnan and S. Niranjali Devaraj, "Morin regulates the expression of NF-B-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma, " Chemico-Biological Interactions, vol. 180, no. 3, pp. 353-359, 2009.
34. A. Lang, R. Schoonhoven, S. Tuvia, D. A. Brenner, and R. A. Rippe, "Nuclear factor B in proliferation, activation, and apoptosis in rat hepatic stellate cells, " Journal of Hepatology, vol. 33, no. 1, pp. 49-58, 2000.
35. A. M. Elsharkawy, M. C. Wright, R. T. Hay et al., "Persistent activation of nuclear factor-B in cultured rat hepatic stellate cells involves the induction of potentially novel rel-like factors and prolonged changes in the expression of IB family proteins, " Hepatology, vol. 30, no. 3, pp. 761-769, 1999.
36. S. L. Friedman, "Evolving challenges in hepatic fibrosis, " Nature Reviews Gastroenterology and Hepatology, vol. 7, no. 8, pp. 425-436, 2010.
37. E. Chávez, K. Reyes-Gordillo, J. Segovia et al., "Resveratrol prevents fibrosis, NF-B activation and TGF-increases induced by chronicCCl4 treatment in rats, " Journal ofApplied Toxicology, vol. 28, no. 1, pp. 35-43, 2008.
38. F. Habens, N. Srinivasan, F. Oakley, D. A. Mann, A. Ganesan, and G. Packham, "Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity, " Apoptosis, vol. 10, no. 3, pp. 481-491, 2005.
39. S. Elmore, "Apoptosis: a review of programmed cell death, " Toxicologic Pathology, vol. 35, no. 4, pp. 495-516, 2007.
40. J. F. Curtin, M. Donovan, and T. G. Cotter, "Regulation and measurement of oxidative stress in apoptosis, " Journal of Immunological Methods, vol. 265, no. 1-2, pp. 49-72, 2002.
41. C. Bubici, S. Papa, K. Dean, and G. Franzoso, "Mutual crosstalk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance, " Oncogene, vol. 25, no. 51, pp. 6731-6748, 2006.
42. M. Parola and G. Robino, "Oxidative stress-related molecules and liver fibrosis, " Journal of Hepatology, vol. 35, no. 2, pp. 297-306, 2001.
43. G. Poli and M. Parola, "Oxidative damage and fibrogenesis, " Free Radical Biology andMedicine, vol. 22, no. 1-2, pp. 287-305, 1997.
44. A. Szuster-Ciesielska, K. Plewka, J. Daniluk, and M. Kandefer-Szerszén, "Zinc supplementation attenuates ethanol-and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling, " Biochemical Pharmacology, vol. 78, no. 3, pp. 301-314, 2009.
45. N. Nieto, P. Greenwel, S. L. Friedman, F. Zhang, A. J. Dannenberg, and A. I. Cederbaum, "Ethanol and arachidonic acid increase 2(I) collagen expression in rat hepatic stellate cells overexpressing cytochrome P450 2E1. Role of H2O2 and cyclooxygenase-2, " The Journal of Biological Chemistry, vol. 275, no. 26, pp. 20136-20145, 2000.
46. K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, "Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships, " Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572-584, 2002.
47. S. Donnapee, J. Li, X. Yang et al., "Cuscuta chinensis Lam. : a systematic review on ethnopharmacology, phytochemistry and pharmacology of an important traditional herbal medicine, " Journal of Ethnopharmacology, vol. 157, pp. 292-308, 2014.